Eli Lilly and Co's blockbuster new drug "Tirzepatide" has filed its fifth marketing application in China.

On December 14, the latest announcement on the CDE website states that Eli Lilly and Co (LLY.US) has had its new indication application for the blockbuster drug GIP/GLP-1 receptor dual agonist tirzepatide injection accepted.

Zhitong FinanceDec 15 16:19

Broadcom rises over 8% again, with a cumulative increase of over 35% in two days! Which company will become the next member of the "trillion Market Cap club"?

After Broadcom's market cap exceeded one trillion dollars, there are currently nine companies in the "trillion-dollar market cap club" in the U.S. stock market, namely Apple, Microsoft, NVIDIA, Amazon, Google, Meta, Tesla, Broadcom, and Taiwan Semiconductor.

Futu NewsDec 16 22:52

Novo's New Deal May End Wegovy Shortages. It Could Reshape the Pharma Industry Along the Way. -- Barrons.com

Barron's06:03

Insurer Stocks Tumble. Trump Echoes Drug Industry Attacks on PBMs. -- Barrons.com

Barron's03:03

Moderna Remains the Most Shorted Among S&P 500 Healthcare Stocks in November

Seeking Alpha02:05

Express News | Trump: 'We're Going to Knock Out the Middlemen' Who Are Keeping Drug Prices High

Breakings00:47